| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.996 | 43.144 | 47.307 | 61.865 | 66.065 | 73.167 | 95.443 | 118.391 | 122.302 | 120.011 |
| Total Income - EUR | 38.012 | 43.173 | 47.346 | 61.886 | 66.097 | 73.903 | 95.530 | 118.568 | 122.648 | 120.490 |
| Total Expenses - EUR | 17.600 | 18.426 | 21.143 | 25.359 | 28.097 | 24.577 | 26.402 | 28.180 | 38.003 | 35.249 |
| Gross Profit/Loss - EUR | 20.412 | 24.747 | 26.202 | 36.527 | 38.000 | 49.326 | 69.129 | 90.388 | 84.645 | 85.241 |
| Net Profit/Loss - EUR | 19.272 | 24.316 | 25.729 | 35.908 | 37.340 | 48.594 | 68.193 | 89.242 | 83.603 | 81.807 |
| Employees | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Alexa Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.605 | 6.850 | 4.246 | 2.559 | 0 | 0 | 0 | 532 | 227 | 0 |
| Current Assets | 36.712 | 48.316 | 55.830 | 40.360 | 45.770 | 59.941 | 77.814 | 96.556 | 129.579 | 117.328 |
| Inventories | 786 | 1.296 | 4.018 | 718 | 75 | 0 | 0 | 0 | 208 | 261 |
| Receivables | 3.998 | 4.092 | 4.042 | 6.023 | 5.296 | 6.710 | 9.434 | 66.520 | 109.375 | 1.450 |
| Cash | 31.928 | 42.928 | 47.770 | 33.619 | 40.399 | 53.231 | 68.380 | 30.036 | 19.997 | 115.617 |
| Shareholders Funds | 24.625 | 29.615 | 54.842 | 41.022 | 42.354 | 53.513 | 68.241 | 89.291 | 116.011 | 104.277 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.692 | 25.551 | 5.235 | 1.896 | 3.416 | 6.428 | 9.572 | 7.798 | 13.796 | 13.051 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alexa Med S.r.l.